TransMedics (TMDX) Gross Margin (2018 - 2026)

TransMedics' Gross Margin history runs 9 years deep, the most recent figure standing at 58.16% for Q1 2026.

• In Q1 2026, Gross Margin fell 331.0% year-over-year to 58.16%; the TTM figure through Mar 2026 stood at 59.09% (down 38.0% YoY), while the FY2025 annual figure was 59.92%, up 56.0% from the prior year.
• Gross Margin was 58.16% for Q1 2026 at TransMedics, roughly flat from 58.11% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 76.22% in Q1 2022 to a low of 55.94% in Q3 2024.
• Historically, Gross Margin has averaged 63.4% across 5 years, with a median of 61.38% in 2025.
• The sharpest annual moves came in 2022 and 2024: Gross Margin jumped 801 bps in 2022, then plunged 944 bps in 2024.
• A 5-year view of Gross Margin shows it stood at 65.99% in 2022, then fell by 11 bps to 59.04% in 2023, then grew by 0 bps to 59.21% in 2024, then decreased by 2 bps to 58.11% in 2025, then climbed by 0 bps to 58.16% in 2026.
• The last three Gross Margin figures came in at 58.16% (Q1 2026), 58.11% (Q4 2025), and 58.8% (Q3 2025), per Business Quant data.